Platelets Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting platelets clinical trials across 5 countries. Studies span Not Applicable, Phase 2. Top locations include Amarillo, Texas, United States, Amiens, France, Ann Arbor, Michigan, United States. Updated daily from ClinicalTrials.gov.


Platelets Trials at a Glance

8 actively recruiting trials for platelets are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Amarillo, Amiens, and Ann Arbor. Lead sponsors running platelets studies include Center for International Blood and Marrow Transplant Research, Centre Hospitalier Universitaire, Amiens, and Ain Shams University.

Browse platelets trials by phase

About Platelets Clinical Trials

Looking for clinical trials for Platelets? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Platelets trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Platelets clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hodgkin LymphomaNon-Hodgkin LymphomaHematologic Malignancies+14 more
Center for International Blood and Marrow Transplant Research99,999 enrolled142 locationsNCT01351545
Recruiting
Not Applicable

Platelets Activation in Brain Neoplasms

Brain NeoplasmsGliomaInflammation+1 more
Fondation Ophtalmologique Adolphe de Rothschild50 enrolled1 locationNCT05049148
Recruiting
Phase 2

Delayed Cold-Stored Platelets -PLTS-1

BleedingCardiac SurgeryCardiopulmonary Bypass+1 more
University Health Network, Toronto150 enrolled2 locationsNCT06147531
Recruiting

Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.

Intensive Care UnitPlateletsNeutrophils to Lymphocytes+4 more
Ain Shams University290 enrolled1 locationNCT07200817
Recruiting
Not Applicable

grouP O wholE blooD : storagE leSion impacT And infLammation

TransfusionBlood DonationInflammation+2 more
Etablissement Français du Sang30 enrolled1 locationNCT06809010
Recruiting
Not Applicable

Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia

PlateletsHeparin-induced ThrombocytopeniaHIT+5 more
Centre Hospitalier Universitaire, Amiens200 enrolled1 locationNCT06033300
Recruiting
Not Applicable

Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis

Meniscus DisorderOsteoarthritis Knees BothPlatelets-rich Plasma+1 more
Xijing Hospital300 enrolled1 locationNCT06082531
Recruiting

Platelet and Autotransfusion Device in Cardiac Surgery

PlateletsAutotransfusion Device
University Hospital, Strasbourg, France100 enrolled1 locationNCT06629311